JL
Jarrod Longcor
Chief Operating Officer

Jarrod Longcor insider trades: Cellectar Biosciences (CLRB) stock buys and sales

Chief Operating Officer, Cellectar Biosciences Last trade May 7, 2026 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$25K
Bought, last 12 months
1 buy
8
Open-market trades
since 2018
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jarrod reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 7, 2026CLRB↑ Buy$25K
Jul 2, 2025CLRB↑ Buy$50K
Jan 10, 2025CLRB↑ Buy$8K
Dec 28, 2020CLRB↑ Buy$40K
Jun 5, 2020CLRB↑ Buy$75K
Feb 28, 2019CLRB↑ Buy$200
Aug 16, 2018CLRB↑ Buy$1K
Mar 13, 2018CLRB↓ Sell$15K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CLRB insiders

Open-market trades in the last 12 months

About Jarrod Longcor's insider trades

Jarrod Longcor is Chief Operating Officer at Cellectar Biosciences (CLRB). Since Mar 13, 2018, Jarrod has reported 7 open-market purchases worth $200K and 1 sale worth $15K on SEC Form 4. In the last 12 months: 1 buy ($25K).

Their filings also include grants and awards (13 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLRB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.